Usefulness of Oral Fluid for Measurement of Methylone and Its Metabolites: Correlation with Plasma Drug Concentrations and the Effect of Oral Fluid pH

The aim of this study was to investigate methylone and its metabolites concentration in oral fluid following controlled increasing doses, focusing on the effect of oral fluid pH. Samples were obtained from a clinical trial where twelve healthy volunteers participated after ingestion of 50, 100, 150...

Full description

Saved in:
Bibliographic Details
Published inMetabolites Vol. 13; no. 4; p. 468
Main Authors Sprega, Giorgia, Di Giorgi, Alessandro, Poyatos, Lourdes, Papaseit, Esther, Pérez-Mañá, Clara, Tini, Anastasio, Pichini, Simona, Busardò, Francesco Paolo, Lo Faro, Alfredo Fabrizio, Farré, Magí
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 24.03.2023
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The aim of this study was to investigate methylone and its metabolites concentration in oral fluid following controlled increasing doses, focusing on the effect of oral fluid pH. Samples were obtained from a clinical trial where twelve healthy volunteers participated after ingestion of 50, 100, 150 and 200 mg of methylone. Concentration of methylone and its metabolites 4-hydroxy-3-methoxy-N-methylcathinone (HMMC) and 3,4-methylenedioxycathinone in oral fluid were measured using liquid chromatography–tandem mass spectrometry (LC–MS/MS). Pharmacokinetic parameters were estimated, and the oral fluid-to-plasma ratio (OF/P) at each time interval was calculated and correlated with the oral fluid pH using data from our previous study in plasma. Methylone was detected at all time intervals after each dose; MDC and HMMC were not detectable after the lowest dose. Oral fluid concentrations of methylone ranged between 88.3–503.8, 85.5–5002.3, 182.8–13,201.8 and 214.6–22,684.6 ng/mL following 50, 100, 150 and 200 mg doses, respectively, peaked between 1.5 and 2.0 h, and were followed by a progressive decrease. Oral fluid pH was demonstrated to be affected by methylone administration. Oral fluid is a valid alternative to plasma for methylone determination for clinical and toxicological studies, allowing for a simple, easy and non-invasive sample collection.
AbstractList The aim of this study was to investigate methylone and its metabolites concentration in oral fluid following controlled increasing doses, focusing on the effect of oral fluid pH. Samples were obtained from a clinical trial where twelve healthy volunteers participated after ingestion of 50, 100, 150 and 200 mg of methylone. Concentration of methylone and its metabolites 4-hydroxy-3-methoxy-N-methylcathinone (HMMC) and 3,4-methylenedioxycathinone in oral fluid were measured using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Pharmacokinetic parameters were estimated, and the oral fluid-to-plasma ratio (OF/P) at each time interval was calculated and correlated with the oral fluid pH using data from our previous study in plasma. Methylone was detected at all time intervals after each dose; MDC and HMMC were not detectable after the lowest dose. Oral fluid concentrations of methylone ranged between 88.3-503.8, 85.5-5002.3, 182.8-13,201.8 and 214.6-22,684.6 ng/mL following 50, 100, 150 and 200 mg doses, respectively, peaked between 1.5 and 2.0 h, and were followed by a progressive decrease. Oral fluid pH was demonstrated to be affected by methylone administration. Oral fluid is a valid alternative to plasma for methylone determination for clinical and toxicological studies, allowing for a simple, easy and non-invasive sample collection.
The aim of this study was to investigate methylone and its metabolites concentration in oral fluid following controlled increasing doses, focusing on the effect of oral fluid pH. Samples were obtained from a clinical trial where twelve healthy volunteers participated after ingestion of 50, 100, 150 and 200 mg of methylone. Concentration of methylone and its metabolites 4-hydroxy-3-methoxy-N-methylcathinone (HMMC) and 3,4-methylenedioxycathinone in oral fluid were measured using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Pharmacokinetic parameters were estimated, and the oral fluid-to-plasma ratio (OF/P) at each time interval was calculated and correlated with the oral fluid pH using data from our previous study in plasma. Methylone was detected at all time intervals after each dose; MDC and HMMC were not detectable after the lowest dose. Oral fluid concentrations of methylone ranged between 88.3-503.8, 85.5-5002.3, 182.8-13,201.8 and 214.6-22,684.6 ng/mL following 50, 100, 150 and 200 mg doses, respectively, peaked between 1.5 and 2.0 h, and were followed by a progressive decrease. Oral fluid pH was demonstrated to be affected by methylone administration. Oral fluid is a valid alternative to plasma for methylone determination for clinical and toxicological studies, allowing for a simple, easy and non-invasive sample collection.The aim of this study was to investigate methylone and its metabolites concentration in oral fluid following controlled increasing doses, focusing on the effect of oral fluid pH. Samples were obtained from a clinical trial where twelve healthy volunteers participated after ingestion of 50, 100, 150 and 200 mg of methylone. Concentration of methylone and its metabolites 4-hydroxy-3-methoxy-N-methylcathinone (HMMC) and 3,4-methylenedioxycathinone in oral fluid were measured using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Pharmacokinetic parameters were estimated, and the oral fluid-to-plasma ratio (OF/P) at each time interval was calculated and correlated with the oral fluid pH using data from our previous study in plasma. Methylone was detected at all time intervals after each dose; MDC and HMMC were not detectable after the lowest dose. Oral fluid concentrations of methylone ranged between 88.3-503.8, 85.5-5002.3, 182.8-13,201.8 and 214.6-22,684.6 ng/mL following 50, 100, 150 and 200 mg doses, respectively, peaked between 1.5 and 2.0 h, and were followed by a progressive decrease. Oral fluid pH was demonstrated to be affected by methylone administration. Oral fluid is a valid alternative to plasma for methylone determination for clinical and toxicological studies, allowing for a simple, easy and non-invasive sample collection.
Audience Academic
Author Pichini, Simona
Lo Faro, Alfredo Fabrizio
Tini, Anastasio
Papaseit, Esther
Poyatos, Lourdes
Sprega, Giorgia
Farré, Magí
Pérez-Mañá, Clara
Di Giorgi, Alessandro
Busardò, Francesco Paolo
AuthorAffiliation 4 National Centre on Addiction and Doping, Istituto Superiore di Sanità, 00161 Rome, Italy
1 Department of Excellence-Biomedical Sciences and Public Health, Università Politecnica delle Marche, 60126 Ancona, Italy
3 Department of Pharmacology, Therapeutics and Toxicology and Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona (UAB), 08193 Cerdanyola del Vallés, Spain
2 Department of Clinical Pharmacology, Hospital Universitari Germans Trias i Pujol and Institut de Recerca Germans Trias i Pujol (HUGTiP-IGTP), 08916 Badalona, Spain
AuthorAffiliation_xml – name: 1 Department of Excellence-Biomedical Sciences and Public Health, Università Politecnica delle Marche, 60126 Ancona, Italy
– name: 2 Department of Clinical Pharmacology, Hospital Universitari Germans Trias i Pujol and Institut de Recerca Germans Trias i Pujol (HUGTiP-IGTP), 08916 Badalona, Spain
– name: 4 National Centre on Addiction and Doping, Istituto Superiore di Sanità, 00161 Rome, Italy
– name: 3 Department of Pharmacology, Therapeutics and Toxicology and Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona (UAB), 08193 Cerdanyola del Vallés, Spain
Author_xml – sequence: 1
  givenname: Giorgia
  surname: Sprega
  fullname: Sprega, Giorgia
– sequence: 2
  givenname: Alessandro
  surname: Di Giorgi
  fullname: Di Giorgi, Alessandro
– sequence: 3
  givenname: Lourdes
  orcidid: 0000-0002-4641-8600
  surname: Poyatos
  fullname: Poyatos, Lourdes
– sequence: 4
  givenname: Esther
  surname: Papaseit
  fullname: Papaseit, Esther
– sequence: 5
  givenname: Clara
  orcidid: 0000-0001-6343-6918
  surname: Pérez-Mañá
  fullname: Pérez-Mañá, Clara
– sequence: 6
  givenname: Anastasio
  surname: Tini
  fullname: Tini, Anastasio
– sequence: 7
  givenname: Simona
  surname: Pichini
  fullname: Pichini, Simona
– sequence: 8
  givenname: Francesco Paolo
  surname: Busardò
  fullname: Busardò, Francesco Paolo
– sequence: 9
  givenname: Alfredo Fabrizio
  orcidid: 0000-0002-0240-5277
  surname: Lo Faro
  fullname: Lo Faro, Alfredo Fabrizio
– sequence: 10
  givenname: Magí
  orcidid: 0000-0001-8338-7543
  surname: Farré
  fullname: Farré, Magí
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37110127$$D View this record in MEDLINE/PubMed
BookMark eNp1kk1v1DAQhiNUREvplSOKxIXLFn8kjs0FVUtLV2pVDvRsOc541ysnLrYD6h_h9-Lstku3gkRKonnfeTyTmdfFweAHKIq3GJ1SKtDHHpJqPaaoQhXjL4ojQjCfYcHFwZPvw-IkxjXKF0N1g_Cr4pA2GCNMmqPi920EM7oBYiy9KW-CcuWFG21XGh_Ka1BxDNDDkCb1GtLq3uUaSjV05SLFKZIrcDZB_FTOfQjgVLJ-KH_ZtCq_ORV7VX4J4zKLg86YsJHjBpBWUJ4bAzo9O_ru8k3x0igX4eThfVzcXpx_n1_Orm6-LuZnVzNd1yTlJzS64xxrXGvcac6B1nXLW4YFJUhoDERg1tSMQVNRAYK3gkJlJp0ZTY-LxZbbebWWd8H2KtxLr6zcBHxYShWS1Q6kJnWnCWZto1glOsVbyniLRAUakEEmsz5vWXdj20O37dbtQfeVwa7k0v-UeRQVZYhmwocHQvA_RohJ9jZqcE4N4McoCUeNIJQ1IlvfP7Ou_RiG_K8mF6s5Jtm5cy1V7sAOxueD9QSVZ03VVKwiosqu03-48t1Bb3Uet7E5vpfw7mmnuxYf1yobqq1BBx9jACO1TZvJZ7J1uWM5LbDcX-C_hezSHsn_SfgD4jDyUg
CitedBy_id crossref_primary_10_3390_ijms24119387
crossref_primary_10_1208_s12248_024_01012_7
crossref_primary_10_3390_ijms24087395
crossref_primary_10_1007_s11419_023_00671_z
Cites_doi 10.1177/2045125320967197
10.1016/j.forsciint.2016.11.034
10.1093/jat/bkz048
10.1093/jat/bku021
10.1093/jat/16.1.1
10.1038/npp.2016.213
10.1002/cpt1978245563
10.1097/FTD.0b013e3182281975
10.3390/biology10080788
10.1016/j.talanta.2021.122966
10.1124/jpet.121.000531
10.1038/npp.2011.304
10.1016/j.jpba.2016.02.015
10.1016/j.bcp.2013.04.004
10.1016/j.clpt.2003.10.004
10.1093/jat/bkaa134
10.1093/clinchem/47.10.1788
10.1159/000457481
10.1093/jat/bkx055
10.2165/00003088-199223050-00003
10.1093/jat/23.6.452
10.1080/15563650.2017.1312002
10.1016/j.drugalcdep.2021.108962
10.1016/S0014-2999(99)00538-5
10.3389/fphar.2023.1122861
10.1016/j.chroma.2014.11.024
10.1093/jat/bky051
10.1124/dmd.112.050880
10.1097/JCP.0000000000001387
10.1016/S0378-4347(97)00572-0
10.1111/bcpt.13786
10.3390/ijms232314636
ContentType Journal Article
Copyright COPYRIGHT 2023 MDPI AG
2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2023 by the authors. 2023
Copyright_xml – notice: COPYRIGHT 2023 MDPI AG
– notice: 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2023 by the authors. 2023
DBID AAYXX
CITATION
NPM
7QR
8FD
8FE
8FH
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
GNUQQ
HCIFZ
LK8
M7P
P64
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.3390/metabo13040468
DatabaseName CrossRef
PubMed
Chemoreception Abstracts
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
ProQuest Central Student
SciTech Premium Collection
ProQuest Biological Science Collection
Biological Science Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
Chemoreception Abstracts
ProQuest Central (New)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Biological Science Database
ProQuest SciTech Collection
Biotechnology and BioEngineering Abstracts
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList PubMed
Publicly Available Content Database

MEDLINE - Academic
CrossRef


Database_xml – sequence: 1
  dbid: DOA
  name: Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 2218-1989
ExternalDocumentID oai_doaj_org_article_c25dc216b7a649da8b368b094ece0f0f
PMC10143603
A747464294
37110127
10_3390_metabo13040468
Genre Journal Article
GeographicLocations Italy
United States--US
Germany
Spain
GeographicLocations_xml – name: Italy
– name: Spain
– name: United States--US
– name: Germany
GrantInformation_xml – fundername: Instituto de Salud Carlos III
  grantid: PI17/01962; PI20/00879; FI18/00179; PT20/00018
GroupedDBID 53G
5VS
8FE
8FH
AADQD
AAFWJ
AAYXX
AFKRA
AFPKN
AFZYC
ALMA_UNASSIGNED_HOLDINGS
BBNVY
BENPR
BHPHI
CCPQU
CITATION
DIK
GROUPED_DOAJ
HCIFZ
HYE
IAO
ITC
KQ8
LK8
M48
M7P
MODMG
M~E
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PROAC
RPM
NPM
PMFND
7QR
8FD
ABUWG
AZQEC
DWQXO
FR3
GNUQQ
P64
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c552t-c5e7cd881c15c1dc88e355b8b6193209c1e29167566e7439e98b93e4f61936fc3
IEDL.DBID M48
ISSN 2218-1989
IngestDate Wed Aug 27 01:28:45 EDT 2025
Thu Aug 21 18:37:38 EDT 2025
Fri Jul 11 10:38:02 EDT 2025
Fri Jul 25 12:07:55 EDT 2025
Tue Jun 17 22:08:40 EDT 2025
Tue Jun 10 21:02:12 EDT 2025
Thu Jan 02 22:53:14 EST 2025
Tue Jul 01 00:44:20 EDT 2025
Thu Apr 24 23:02:49 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords pharmacokinetics
LC–MS/MS
humans
methylone
oral fluid
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c552t-c5e7cd881c15c1dc88e355b8b6193209c1e29167566e7439e98b93e4f61936fc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
These authors contributed equally to this work.
ORCID 0000-0002-4641-8600
0000-0002-0240-5277
0000-0001-6343-6918
0000-0001-8338-7543
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/metabo13040468
PMID 37110127
PQID 2806581292
PQPubID 2032362
ParticipantIDs doaj_primary_oai_doaj_org_article_c25dc216b7a649da8b368b094ece0f0f
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10143603
proquest_miscellaneous_2807923679
proquest_journals_2806581292
gale_infotracmisc_A747464294
gale_infotracacademiconefile_A747464294
pubmed_primary_37110127
crossref_citationtrail_10_3390_metabo13040468
crossref_primary_10_3390_metabo13040468
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20230324
PublicationDateYYYYMMDD 2023-03-24
PublicationDate_xml – month: 3
  year: 2023
  text: 20230324
  day: 24
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Metabolites
PublicationTitleAlternate Metabolites
PublicationYear 2023
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Mercolini (ref_21) 2016; 123
Hole (ref_35) 2021; 41
Axelsson (ref_28) 2022; 131
ref_32
Mannocchi (ref_12) 2022; 26
Czerwinska (ref_37) 2021; 45
Mas (ref_31) 1999; 290
Cozzi (ref_5) 1999; 381
Cook (ref_33) 1993; 21
Pedersen (ref_34) 2013; 41
Centazzo (ref_8) 2021; 377
Lendoiro (ref_20) 2014; 1374
Krotulski (ref_26) 2018; 42
Shafi (ref_2) 2020; 10
Gorodischer (ref_14) 1992; 19
Navarro (ref_19) 2001; 47
Baumann (ref_6) 2012; 37
Elmore (ref_9) 2017; 42
Poyatos (ref_10) 2023; 14
Mucklow (ref_13) 1978; 24
Oliveira (ref_27) 2021; 227
Miller (ref_24) 2017; 274
Barnes (ref_18) 2011; 33
ref_1
Schramm (ref_15) 1992; 16
Eshleman (ref_7) 2013; 85
Crouch (ref_29) 1999; 23
Uralets (ref_11) 2014; 38
Zaami (ref_3) 2018; 22
Vallersnes (ref_25) 2017; 55
Drobitch (ref_16) 1992; 23
Desrosiers (ref_17) 2019; 43
Giessmann (ref_36) 2004; 75
ref_4
Williams (ref_22) 2017; 41
Denia (ref_23) 2022; 238
Kidwell (ref_30) 1998; 713
References_xml – volume: 10
  start-page: 2045125320967197
  year: 2020
  ident: ref_2
  article-title: New Psychoactive Substances: A Review and Updates
  publication-title: Ther. Adv. Psychopharmacol.
  doi: 10.1177/2045125320967197
– volume: 274
  start-page: 13
  year: 2017
  ident: ref_24
  article-title: Stability of Synthetic Cathinones in Oral Fluid Samples
  publication-title: Forensic Sci. Int.
  doi: 10.1016/j.forsciint.2016.11.034
– volume: 43
  start-page: 415
  year: 2019
  ident: ref_17
  article-title: Oral Fluid Drug Testing: Analytical Approaches, Issues and Interpretation of Results
  publication-title: J. Anal. Toxicol.
  doi: 10.1093/jat/bkz048
– volume: 38
  start-page: 233
  year: 2014
  ident: ref_11
  article-title: Testing for Designer Stimulants: Metabolic Profiles of 16 Synthetic Cathinones Excreted Free in Human Urine
  publication-title: J. Anal. Toxicol.
  doi: 10.1093/jat/bku021
– volume: 16
  start-page: 1
  year: 1992
  ident: ref_15
  article-title: Drugs of Abuse in Saliva: A Review
  publication-title: J. Anal. Toxicol.
  doi: 10.1093/jat/16.1.1
– volume: 42
  start-page: 649
  year: 2017
  ident: ref_9
  article-title: Pharmacokinetic Profiles and Pharmacodynamic Effects for Methylone and Its Metabolites in Rats
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2016.213
– ident: ref_1
– volume: 24
  start-page: 563
  year: 1978
  ident: ref_13
  article-title: Drug Concentration in Saliva
  publication-title: Clin. Pharmacol. Ther.
  doi: 10.1002/cpt1978245563
– volume: 33
  start-page: 602
  year: 2011
  ident: ref_18
  article-title: MDMA and Metabolite Disposition in Expectorated Oral Fluid after Controlled Oral MDMA Administration
  publication-title: Ther. Drug Monit.
  doi: 10.1097/FTD.0b013e3182281975
– ident: ref_32
  doi: 10.3390/biology10080788
– volume: 238
  start-page: 122966
  year: 2022
  ident: ref_23
  article-title: Analysis of Drugs Including Illicit and New Psychoactive Substances in Oral Fluids by Gas Chromatography-Drift Tube Ion Mobility Spectrometry
  publication-title: Talanta
  doi: 10.1016/j.talanta.2021.122966
– volume: 377
  start-page: 398
  year: 2021
  ident: ref_8
  article-title: Brain Concentrations of Methylone and Its Metabolites after Systemic Methylone Administration: Relationship to Pharmacodynamic Effects
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.121.000531
– volume: 37
  start-page: 1192
  year: 2012
  ident: ref_6
  article-title: The Designer Methcathinone Analogs, Mephedrone and Methylone, Are Substrates for Monoamine Transporters in Brain Tissue
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2011.304
– volume: 123
  start-page: 186
  year: 2016
  ident: ref_21
  article-title: LC-MS/MS and Volumetric Absorptive Microsampling for Quantitative Bioanalysis of Cathinone Analogues in Dried Urine, Plasma and Oral Fluid Samples
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/j.jpba.2016.02.015
– volume: 85
  start-page: 1803
  year: 2013
  ident: ref_7
  article-title: Substituted Methcathinones Differ in Transporter and Receptor Interactions
  publication-title: Biochem. Pharmacol.
  doi: 10.1016/j.bcp.2013.04.004
– volume: 75
  start-page: 213
  year: 2004
  ident: ref_36
  article-title: CYP2D6 Genotype and Induction of Intestinal Drug Transporters by Rifampin Predict Presystemic Clearance of Carvedilol in Healthy Subjects
  publication-title: Clin. Pharmacol. Ther.
  doi: 10.1016/j.clpt.2003.10.004
– volume: 26
  start-page: 5033
  year: 2022
  ident: ref_12
  article-title: Targeted Screening and Quantification of Synthetic Cathinones and Metabolites in Hair by UHPLC-HRMS
  publication-title: Eur. Rev. Med. Pharmacol. Sci.
– volume: 45
  start-page: 730
  year: 2021
  ident: ref_37
  article-title: Pharmacokinetics of Mephedrone and Its Metabolites in Whole Blood and Plasma after Controlled Intranasal Administration to Healthy Human Volunteers
  publication-title: J. Anal. Toxicol.
  doi: 10.1093/jat/bkaa134
– volume: 47
  start-page: 1788
  year: 2001
  ident: ref_19
  article-title: Usefulness of Saliva for Measurement of 3,4-Methylenedioxymethamphetamine and Its Metabolites: Correlation with Plasma Drug Concentrations and Effect of Salivary PH
  publication-title: Clin. Chem.
  doi: 10.1093/clinchem/47.10.1788
– volume: 19
  start-page: 161
  year: 1992
  ident: ref_14
  article-title: Salivary Excretion of Drugs in Children: Theoretical and Practical Issues in Therapeutic Drug Monitoring
  publication-title: Dev. Pharmacol. Ther.
  doi: 10.1159/000457481
– volume: 22
  start-page: 268
  year: 2018
  ident: ref_3
  article-title: Synthetic Cathinones Related Fatalities: An Update
  publication-title: Eur. Rev. Med. Pharmacol. Sci.
– volume: 41
  start-page: 659
  year: 2017
  ident: ref_22
  article-title: A Validated Method for the Detection of 32 Bath Salts in Oral Fluid
  publication-title: J. Anal. Toxicol.
  doi: 10.1093/jat/bkx055
– volume: 23
  start-page: 365
  year: 1992
  ident: ref_16
  article-title: Therapeutic Drug Monitoring in Saliva. An Update
  publication-title: Clin. Pharmacokinet.
  doi: 10.2165/00003088-199223050-00003
– volume: 23
  start-page: 452
  year: 1999
  ident: ref_29
  article-title: Correlation of Saliva Codeine Concentrations with Plasma Concentrations after Oral Codeine Administration
  publication-title: J. Anal. Toxicol.
  doi: 10.1093/jat/23.6.452
– volume: 55
  start-page: 636
  year: 2017
  ident: ref_25
  article-title: Underestimated Impact of Novel Psychoactive Substances: Laboratory Confirmation of Recreational Drug Toxicity in Oslo, Norway
  publication-title: Clin. Toxicol.
  doi: 10.1080/15563650.2017.1312002
– volume: 227
  start-page: 108962
  year: 2021
  ident: ref_27
  article-title: Prevalence of New Psychoactive Substances (NPS) in Brazil Based on Oral Fluid Analysis of Samples Collected at Electronic Music Festivals and Parties
  publication-title: Drug Alcohol. Depend.
  doi: 10.1016/j.drugalcdep.2021.108962
– volume: 381
  start-page: 63
  year: 1999
  ident: ref_5
  article-title: Inhibition of Plasma Membrane Monoamine Transporters by Beta-Ketoamphetamines
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/S0014-2999(99)00538-5
– volume: 14
  start-page: 1122861
  year: 2023
  ident: ref_10
  article-title: Pharmacological Effects of Methylone and MDMA in Humans
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2023.1122861
– volume: 1374
  start-page: 93
  year: 2014
  ident: ref_20
  article-title: Liquid Chromatography Tandem Mass Spectrometry Determination of Selected Synthetic Cathinones and Two Piperazines in Oral Fluid. Cross Reactivity Study with an on-Site Immunoassay Device
  publication-title: J. Chromatogr. A
  doi: 10.1016/j.chroma.2014.11.024
– volume: 42
  start-page: 544
  year: 2018
  ident: ref_26
  article-title: The Detection of Novel Stimulants in Oral Fluid from Users Reporting Ecstasy, Molly and MDMA Ingestion
  publication-title: J. Anal. Toxicol.
  doi: 10.1093/jat/bky051
– volume: 41
  start-page: 1247
  year: 2013
  ident: ref_34
  article-title: In Vitro Metabolism and Pharmacokinetic Studies on Methylone
  publication-title: Drug Metab. Dispos.
  doi: 10.1124/dmd.112.050880
– volume: 41
  start-page: 281
  year: 2021
  ident: ref_35
  article-title: Dose-Dependent Inhibition of CYP2D6 by Bupropion in Patients With Depression
  publication-title: J. Clin. Psychopharmacol.
  doi: 10.1097/JCP.0000000000001387
– volume: 290
  start-page: 136
  year: 1999
  ident: ref_31
  article-title: Cardiovascular and Neuroendocrine Effects and Pharmacokinetics of 3, 4-Methylenedioxymethamphetamine in Humans
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 713
  start-page: 111
  year: 1998
  ident: ref_30
  article-title: Testing for Drugs of Abuse in Saliva and Sweat
  publication-title: J. Chromatogr. B Biomed. Sci. Appl.
  doi: 10.1016/S0378-4347(97)00572-0
– volume: 131
  start-page: 420
  year: 2022
  ident: ref_28
  article-title: Retrospective Identification of New Psychoactive Substances in Patient Samples Submitted for Clinical Drug Analysis
  publication-title: Basic Clin. Pharmacol. Toxicol.
  doi: 10.1111/bcpt.13786
– volume: 21
  start-page: 717
  year: 1993
  ident: ref_33
  article-title: Pharmacokinetics of Methamphetamine Self-Administered to Human Subjects by Smoking S-(+)-Methamphetamine Hydrochloride
  publication-title: Drug Metab. Dispos.
– ident: ref_4
  doi: 10.3390/ijms232314636
SSID ssj0000605701
Score 2.2634852
Snippet The aim of this study was to investigate methylone and its metabolites concentration in oral fluid following controlled increasing doses, focusing on the...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 468
SubjectTerms Abstinence
Chemical properties
Chromatography
Cocaine
Dosage and administration
Drug dosages
Drug metabolism
Drug testing
humans
Ions
LC–MS/MS
Liquid chromatography
Mandatory drug testing
Mass spectrometry
Mass spectroscopy
Metabolites
Methamphetamine
Methods
methylone
oral fluid
pH effects
Pharmaceutical research
Pharmacokinetics
Physiological aspects
Plasma
Psychotropic drugs
Salivary diagnostics
Scientific imaging
Toxicity testing
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT1wQUB6hBRkJwSlqEjuOzW0prBakAgdW6s2KX1BpN1t1kwN_pL-3M3a6bECIC5ccMrOJ7RnPfOOdzBDyqpYGO1eHPDgRcq58mYOYDVycEeCQwSPEbIvPYrHkn87r871WX5gTlsoDp4U7sVXtbFUK07SCK9dKw4Q0EJR464tQBLS-4PP2gqlkgwGHFGWq0sggrj9Z-x5WFSw2h4hQTrxQLNb_p0ne80nTfMk9BzS_T-6NyJHO0ogfkDu-e0gOZx1Ezeuf9DWNuZzxkPyQXC-3PgwrNGN0E-gXeBydr4YLRwGj0rNf54JIPfMgrNWm87TtHP3Yb_EOzAK_Tt6-pafYvyNlzFE8taVfAXCvW_r-avgOxC4NN6pvfAAgSppqIv_26svFI7Kcf_h2usjHDgy5reuqh6tvrJOytGVtS2el9IBPjDQCcV-hbOkrwJcNYEKPkY1X0ijmeUC6CJY9JgcdjP8poTW2OWaOtaq2vIWg0ChpIVhED-la7jKS30pE27E8OXbJWGkIU1CCeirBjLzZ8V-mwhx_5XyHAt5xYUHteAPUTI9qpv-lZvA6VA-N2x6GZdvx6wWYHBbQ0jMIyzjEcopn5HjCCdvVTsm3CqZHc7HV8e9tgFqqysjLHRl_iSlwnd8MkQdrPYpGZeRJ0sfdlFhTYp22JiNyoqmTOU8p3cWPWEwcezUzUbBn_2OVjsjdCkAg5uhV_Jgc9FeDfw6grTcv4v68AZ3sQPE
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagvXBBQHkECjISglPUPBzH5oK2pasFqaVCrNRbFD9SKu0myyY58Ef4vcw43rQBwSWHjJPYmfHMfJPJDCFvMqGwc3UVVoZXIZM2DoHNCg5GcTDIYBFctsU5XyzZ58vs0gfcWp9WudOJTlGbRmOM_Mh9AQRrJJMPmx8hdo3Cr6u-hcZdsg8qWAD42j8-Pb_4OkZZIvDW8ygeqjWmgO-P1raDtwuamwEyFBNr5Ir2_62ab9mmad7kLUM0f0Duew-SzgaWPyR3bP2IHMxqQM_rn_QtdTmdLlh-QH4tW1v1K1RntKnoF7gdna_6a0PBV6VnN_FBpJ5ZYNqqqS0ta0M_dS2egVXgX8rte3qCfTyGzDmK0Vt6AY73uqQft_0VEOthuk6M3Q3As6RDbeQ_Hr1ZPCbL-em3k0XoOzGEOsuSDo4210aIWMeZjo0WwoKfooTi6P9FUsc2AT8zB9_QIsKxUiiZWlYhnVc6fUL2apj_M0IzbHecmrSUmWYlgEMlhQbQiJbSlMwEJNxxpNC-TDl2y1gVAFeQg8WUgwF5N47fDAU6_jnyGBk8jsLC2u5Es70q_D4tdJIZncRc5SVn0pRCpVwowMBW26iKKngcikeB2x-mpUv_FwMsDgtpFTOAZwwwnWQBOZyMhG2rp-SdgBVebbTFjZAH5PVIxisxFa62Te_GYM1HnsuAPB3kcVxSmsdYry0PiJhI6mTNU0p9_d0VFceezSmP0uf_n9cLci8BNw-z8BJ2SPa6bW9fglvWqVd-7_0Gwgo5Bg
  priority: 102
  providerName: ProQuest
Title Usefulness of Oral Fluid for Measurement of Methylone and Its Metabolites: Correlation with Plasma Drug Concentrations and the Effect of Oral Fluid pH
URI https://www.ncbi.nlm.nih.gov/pubmed/37110127
https://www.proquest.com/docview/2806581292
https://www.proquest.com/docview/2807923679
https://pubmed.ncbi.nlm.nih.gov/PMC10143603
https://doaj.org/article/c25dc216b7a649da8b368b094ece0f0f
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB5BK6FeEFAepiVaJAQng5_rXSSE0tIoIKVUiEi9Wd6HSyXHaRNHon-E38vM2klrKBcuPnjX9q5nZuf71uMZgFepUFS5uvRLw0s_kTb0UcwKD0ZxdMjoEVy0xTEfT5Mvp-npdfxT9wKXt1I7qic1XVRvf15efUSD_0CMEyn7u5lt8IXhYpwg2RN3YRu9UkZGOumgfrsqIzIJwjZv4y2X7cC9OAsp21XWc1Euk__f6_UNh9UPprzhnUYP4H4HK9mw1YOHcMfWj2B3WCOlnl2x18wFerod9F34NV3aclXRGsfmJfuKt2OjanVuGAJYNrneNKTWiUVJVvPasqI27HOzpDM4Ifp1efmeHVJxjzacjtGWLjtBND4r2KfF6gwb63a4TrfdDRBusjZh8h-Pvhg_huno6Pvh2O_KM_g6TaMGjzbTRohQh6kOjRbCInhRQnEChYHUoY0QfGYIGC3RHiuFkrFNSmrnpY6fwFaN438GLKUayLGJC5nqpEDGqKTQyCTJfZoiMR74a4nkustdTiU0qhw5DAkz7wvTgzeb_hdt1o5_9jwgAW96UbZtd2K-OMs74811lBodhVxlBU-kKYSKuVBIjK22QRmU-DhSj5y0FIeli-7XBpwcZdfKh8jZEiR6MvFgv9cTbVn3m9cKlq9NIXffvhGHyciDl5tmupLi42o7X7k-lAiSZ9KDp60-bqa0VmsPRE9Te3Put9TnP1ymcSrkHPMgfv7_l-7BToS4kML2omQftprFyr5AHNeoAWwfHB2ffBu4fZCBM9ffzUBLCQ
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6V9AAXBJSHocAi8ThZ9WNtr5EQSh9RQptQoUbqzXgfLpUSJ-Qh1D_Cz-A3MrN20pqq3HrxwbNe72pmZ-bbnZ0BeBsJSZWrC7fQceHy1PguslniQ8sYDTJaBBttMYi7Q_7lNDrdgD-ruzAUVrnSiVZR64miPfIdewKI1igNPk9_ulQ1ik5XVyU0KrE4NBe_ELLNP_X2kb_vgqBzcLLXdeuqAq6KomCBT5MoLYSv_Ej5Wglh0OZKIWPyZbxU-SZAnylBP8eQt25SIdPQ8ILocaFC7PcObPIQoUwLNncPBsff1rs6HqKDxPOr7JBhmHo7Y7NAbqKl4IhERcP62SIB103BFVvYjNO8Yvg6D-B-7bGydiViD2HDlI9gq10iWh9fsPfMxpDazfkt-D2cm2I5IvXJJgX7it2xzmh5rhn6xqx_uR9J1L5BIRlNSsPyUrPeYk5vcBZ0K3r-ke1R3ZAqUo_RbjE7Rkd_nLP92fIMiWU1XLtsbAfoybIqF_M_v552H8PwVnj0BFoljv8ZsIjKK4c6zNNI8RzBqEyFQpBKllnnXDvgrjiSqTotOlXnGGUIj4iDWZODDnxYt59WCUFubLlLDF63okTe9sVkdpbVeiFTQaRV4McyyWOe6lzIMBYSMbdRxiu8An9H4pGRusFhqby-NYGTo8RdWRvhIEcMmXIHthstUU2oJnklYFmtpubZ5aJy4M2aTF9S6F1pJkvbhnJMxknqwNNKHtdTChOf8sMlDoiGpDbm3KSU5z9sEnOqEY1LKHz-_3G9hrvdk_5RdtQbHL6AewG6mBQBGPBtaC1mS_MSXcKFfFWvQwbfb3vp_wUF4XR_
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVEJcEFAehgKLxONkxW_vIiGUNo0SSkOEiNSb8T5cKiVOyEOof4Qfw69jZu2kNQhuvfjgWa93PbMz861nZwBexlxS5erCLXRSuJEwvotslnjRMkGDjBbBRlsMk_44-nAan-7Ar81ZGAqr3OhEq6j1TNEeedv-AURrJIJ2UYdFjLq99_PvLlWQoj-tm3IalYgcm4sfCN-W7wZd5PWrIOgdfTnsu3WFAVfFcbDCq0mV5txXfqx8rTg3aH8llwn5NZ5QvgnQf0rR5zHkuRvBpQhNVBA9KVSI_d6A3RRRkdeC3YOj4ejzdofHQ6SQen6VKTIMhdeemhVyFq1GhKiUNyyhLRjwt1m4YhebMZtXjGDvDtyuvVfWqcTtLuyY8h7sdUpE7tML9prZeFK7Ub8HP8dLg9-QVCmbFewTdsd6k_W5Zugns5PLvUminhgUmMmsNCwvNRuslnQHZ0EnpJdv2SHVEKmi9hjtHLMROv3TnHUX6zMkltVw7RKyHaBXy6q8zH-8et6_D-Nr4dEDaJU4_kfAYiq1HOowF7GKcgSmUnCFgJWstM4j7YC74Uim6hTpVKljkiFUIg5mTQ468Gbbfl4lB_lnywNi8LYVJfW2N2aLs6zWEZkKYq0CP5FpnkRC51yGCZeIv40yXuEV-DoSj4xUDw5L5fUJCpwcJfHKOggNI8STInJgv9ESVYZqkjcCltUqa5ldLjAHXmzJ9CSF4ZVmtrZtKN9kkgoHHlbyuJ1SmPqUKy51gDcktTHnJqU8_2YTmlO96DDxwsf_H9dzuIlLPvs4GB4_gVsBepsUDBhE-9BaLdbmKXqHK_msXoYMvl73yv8NZ-x4tA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Usefulness+of+Oral+Fluid+for+Measurement+of+Methylone+and+Its+Metabolites%3A+Correlation+with+Plasma+Drug+Concentrations+and+the+Effect+of+Oral+Fluid+pH&rft.jtitle=Metabolites&rft.au=Sprega%2C+Giorgia&rft.au=Di+Giorgi%2C+Alessandro&rft.au=Poyatos%2C+Lourdes&rft.au=Papaseit%2C+Esther&rft.date=2023-03-24&rft.pub=MDPI&rft.eissn=2218-1989&rft.volume=13&rft.issue=4&rft_id=info:doi/10.3390%2Fmetabo13040468&rft_id=info%3Apmid%2F37110127&rft.externalDocID=PMC10143603
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2218-1989&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2218-1989&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2218-1989&client=summon